This review covers a number of aspects of the behaviour of oligodendrocyte progenitors following transplantation into the adult CNS. First, an account is given of the ability of transplanted oligodendrocyte progenitors, grown in tissue culture in the presence of PDGF and bFGF, to extensively remyelinate focal areas of persistent demyelination. Secondly, we describe how transplanted clonal cell lines of oligodendrocyte progenitors will differentiate into astrocytes as well oligodendrocytes following transplantation into pathological environments in which both oligodendrocytes and astrocytes are absent, thereby manifesting the bipotentially demonstrable in vitro but not during development. Finally, a series of studies examining the migratory behaviour of transplanted oligodendrocyte progenitors (modelled using the oliodendrocyte progenitor cell line CG4) are described. These show that CG4 cells do not survive (or migrate) when transplanted into the normal adult CNS. However, if they are transplanted into CNS tissue that has previously been exposed to 40 Gy of -irradiation then transplanted CG4 cells survive, divide and migrate over large distances. Moreover, within an -irradiated environment, migrating transplanted CG4 cells are able to enter remotely located foci of demyelination and contribute to the remyelination of the demyelinated axons within. These studies demonstrate that although the normal adult CNS does not appear to support survival and migration of the CG4 cell line, it is possible to manipulate the environment in such a way that these nonpermissive properties of the environment can be overcome.

The development of techniques for studying the myelinogenic capacity of transplanted glia has undoubtedly provided a new impetus to the study of the oligodendrocyte in development and pathology (reviewed by Blakemore & Franklin, 1991 ; Franklin, 1993 ; Duncan, 1996) . The progress that has been made in this field over the past decade can be attributed to advances in 2 main areas : (1) the development of recipient environments that are deficient in glial cells, thereby providing niches for transplanted cells to occupy, and (2) improvements in our understanding of the various phenotypic stages of the oligodendrocyte (OL) lineage.
The glia-deficient environments into which OL lineage cells have been transplanted fall into 2
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categories. The first of these are the so-called ' myelin mutants ', where a defect in one of the genes encoding central myelin proteins (such as the MBP-mutant shiverer mouse, or the PLP-mutant myelin-deficient rat) gives rise to a hypomyelinated CNS containing abundant unmyelinated or demyelinated axons available for myelination by transplanted cells. In general, the myelin mutants are short-lived, and most studies using these animals have been undertaken in neonatal or immature recipients (Duncan et al. 1988 ; Gumpel et al. 1989 ; Rosenbluth et al. 1990) . Two myelin mutants that are particularly noteworthy in the context of OL lineage transplant studies are the shaking pup, a PLP mutant (Nadon et al. 1990) , because it provides a large area of myelin deficiency with which to rigorously test the ability of transplanted cells to myelinate over a large area (Archer et al. 1992) , and the taiep rat (Duncan et al. 1992 a) because its longevity permits longer term studies than are possible with the shorter-lived rodent mutants.
The second transplantation model involves the creation of clearly defined focal areas of demyelination within the white matter of adult animals by the direct injection of small volumes of gliotoxic agents such as lysolecithin or ethidium bromide (EB). The normally-occurring, spontaneous remyelination of gliotoxin-induced areas of demyelination can be prevented by exposing the lesion area to 40 Gy of -irradiation, thereby creating a nonrepairing area of demyelination (the X-EB lesion) with which to test the behaviour of transplanted cells in the absence of competition from recruited host cells (Blakemore & Franklin, 1991 ; Franklin & Blakemore, 1995) (Fig.  1 a) . Other myelin-deficient environments that have been used in transplant studies include the retina (Huang et al. 1991 ) and the CNS of normal neonates before myelination is complete (Freidrich & Lazzarini, 1993 ; Lachapelle et al. 1994) . The ability of transplants containing cells of the oligodendrocyte lineage to myelinate host axons has been clearly demonstrated using all these models.
The second key aspect of the glial transplantation paradigm is the composition of the transplanted population. In the early studies, myelinating cells were transplanted in the form of tissue fragments, a relatively crude approach in which the identity of the cell types present within the graft that were responsible for the observed effects could not be established with any degree of certainty (Gumpel et al. 1983) . However, the advances in understanding of oligodendrocyte ontogenesis based on in vitro approaches and the recognition of a variety of markers for specific stages of the oligodendrocyte lineage (Raff et al. 1983 ; Pfeiffer et al. 1993 ) enabled the isolation of populations of cells enriched for particular phenotypes. This made it possible to undertake studies in which the contribution to transplant-mediated myelination of specific stages of the OL lineage could then be individually addressed (Franklin et al. 1991 ; Gansmu$ ller et al. 1991 ; Duncan et al. 1992 b ; Groves et al. 1993 ; Ludwin & Szuchet, 1993 ; Warrington et al. 1993 ). Moreover, it became possible to extend transplant studies on particular stages of the OL lineage following the development of cell lines that more or less faithfully exhibited the behaviour of the phenotypes from which they were derived (Barnett et al. 1993 ; Trotter et al. 1993 ; Tontsch et al. 1994 ; Franklin et al. 1995) . In an elegant and important study by Warrington et al. (1993) it was demonstrated that oligodendrocyte progenitors (A2B5j\O4k) cells produced more myelin over a wider area than did the more mature stages of the lineage (O4j\GalCk and GalCj cells) when transplanted in neonatal shiverer mice. As a consequence of this and other studies (Gansmu$ ller et al. 1991 ; Groves et al. 1993) , the A2B5j oligodendrocyte progenitor (OP) became the focus for a number of subsequent transplantation studies, some of which form the subject of this review.
                
In order to establish the ability of OPs to remyelinate areas of demyelination in the adult CNS, OPs from neonatal rat optic nerve cultures which had been enriched to 99 % purity by exposure to PDGF and bFGF (Bo$ gler et al. 1990) were transplanted directly into X-EB lesions (Groves et al. 1993) . By 21 d following transplantation, as many as 90 % of the available axons had been reinvested with central myelin sheaths, indicating that transplant OPs were able to differentiate into myelinating oligodendrocytes within the lesion environment. Although the host tissue had been -irradiated and therefore was incapable of contributing cells to the repair of the lesion, the transplant origin of the myelinating cells was confirmed by labelling the transplanted cells with the marker gene LacZ (Fig. 1) . The incorporation of the LacZ gene did not affect the ability of the OPs to remyelinate demyelinated axons, indicating that OPs can be engineered to express a foreign protein while still retaining their function. This study also demonstrated the potential for using combinations of growth factors (in this case PDGF and bFGF) to generate large numbers of OPs in vitro as a prelude to transplantation. However, we were also able to show that prolonged in vitro exposure to PDGF\bFGF resulted in continued proliferation of the cells following transplantation, a situation that was associated with a decrease in the extent of remyelination.
A similar degree of remyelination of X-EB lesions can be achieved using some, but not all, OP cell lines. The CG4 cell line can generate large areas of remyelination which resemble those generated by growth factor expanded populations of primaryderived OP cells, albeit with a slightly higher cell density (Franklin et al. 1995) (Fig. 2) . This cell line also remyelinates large areas of the myelin-deficient rat following transplantation (Tontsch et al. 1994 ). On the other hand, one OP cell line created by incorporation of the SV40 oncogene, while capable of Groves et al. 1993) . The transplant-origin of this cell is evident from the distribution of electron dense crystals of the reaction product generated histochemically in cells expressing the LacZ gene. The reaction product, most evident in unstained resin sections such as these, is typically distributed around the nucleus and within the cytoplasm. Bar, 1 µm. (b) At higher power a process from the cell in Figure 1a containing crystals of reaction product (arrows) can be seen attached to a myelinated axon (the same axon as that indicated by an asterisk in (a). Bar, 0n5 µm. 
             -    
It is now common knowledge that the O-2A progenitor is so-called because in vitro this cell, which constitutively gives rise to an oligodendrocyte, can also be induced to generate a GFAP-expressing cell, the type-2 astrocyte (Raff et al. 1983) . Despite an extensive search, it has not been possible to demonstrate that this is a differentiation pathway taken by the OP cell during normal development (Skoff, 1990 ; Fulton et al. 1992 ; Espinosa de los Monteros et al. 1993 ; reviewed in Franklin & Blakemore, 1995) . Nevertheless, we endeavoured to establish whether an OP cell could give rise to a type-2 astrocyte in vivo in pathological situations in which both oligodendrocytes and astrocytes are absent. Such a situation exists in the X-EB lesion ( Fig. 1 a) , which therefore constitutes an environment quite different from that which occurs in development. In order to address questions of lineage by cell transplantation it is imperative to use populations of proven purity (Barnett et al. 1993 ; Franklin & Blakemore, 1995 ; Franklin et al. 1986 b) . Populations of progenitors which contain other phenotypes, however small the contaminant populations may be, are inadequate in that the heterogeneity of the starting population introduces uncertainty about the origin of differentiated phenotypes subsequently identified. In our experience, sufficient purity cannot be obtained from primary cultures. Even PDGF\bFGF-expanded populations of OPs, although 99 % pure, contained small numbers of other phenotypes. For this reason we have used OP cell lines whose clonality can be verified. The first of these OP lines was created from PDGF\bFGF-treated cultures of neonatal rat optic nerve using a temperature-sensitive mutant form of the SV40 oncogene (Barnett et al. 1993) . This oncogene product is active at 33 mC but inactive at 39 mC, and therefore inactive following transplantation into a rat host. The clonal nature of the line so generated was verified by Southern blot analysis of genomic DNA.
When a pure population of A2B5-expressing OP cells, obtained by maintaining the line at 33 mC in the presence of PDGF\bFGF, was transplanted into X-EB lesions, the majority of cells remained as progenitors. However, a small proportion differentiated into myelinating oligodendrocytes or cells which were identified as astrocytes on the basis of ultrastructural features and GFAP-expression (Fig. 3) . This was the first demonstration in vivo of cells akin to the type-2 astrocytes of tissue culture. That this behaviour was not a peculiarity of the SV40 line was confirmed by demonstrating a similar phenomenon using the CG4 cell line (Franklin et al. 1995) . The OP origin of the astrocytes within the lesion was unequivocally demonstrated by the presence of GFAPj\LacZ ' blue 'j cells following the transplantation of lacZ-labelled CG4s. The astrocyte generated from an OP has a distinct behaviour and morphology which distinguish it from other types of astrocyte that have been transplanted into X-EB lesions (Franklin & Blakemore, 1995) . Thus, in pathological situations in which there is a deficiency in both oligodendrocytes and astrocytes, OPs manifest a bipotentiality hitherto only seen in tissue culture.
    4  (    )    
The success that has been achieved in remyelinating persistent areas of demyelination by glial cell transplantation in animal models has inevitably fostered a belief that such an approach may be appropriate for the repair of areas of chronic demyelination in diseases such as multiple sclerosis (MS). Before such a transition can be made there are, of course, a great many additional issues that need addressing. Since MS is a multifocal condition, with areas or ' plaques ' of demyelination occurring throughout the neuraxis, an issue of some relevance is the migratory behaviour of OPs following transplantation into the adult CNS. Would OPs need to be injected directly into plaques, or would the migratory behaviour of OPs in vitro (Small et al. 1987 ; Armstrong et al. 1990 ), in development (Kiernan & ffrench-Constant, 1993 ; Levison et al. 1993) or following transplantation into normal or mutant neonates (Baulac et al. 1987 ; Jacque et al. 1992 ; Freidrich & Lazzarini, 1993 ; Lachapelle et al. 1994 ) enable transplanted OPs to migrate through normal tissue and enter areas of demyelination ? There is some evidence from both shiverer and normal mouse that transplanted OP cells are able to migrate into lesions (Gout et al. 1988 ; Vignais et al. 1993 ; Baron-Van Evercooren et al. 1996) , in which case it might not be necessary to make separate injections directly into each clinically relevant plaque. To further address this issue we have conducted a series of experiments using the CG4 cell line, the behaviour of which mimics closely the behaviour of OPs from primary culture following transplantation (Franklin et al. 1995) . The CG4 cells were labelled with the LacZ marker gene to enable identification of transplanted cells within host tissue (Franklin et al. 1996 a) (summarised in Fig.  4) .
Transplanted CG4 cells migrate extensively through unlesioned X-irradiated spinal cord
In an initial experiment CG4 cells were injected into the right ventral white matter of rats whose spinal cords had been exposed to 40 Gy of -irradiation. An important aspect of migration studies is to ascertain the extent of passive spread of cells that is attributable solely to the injection procedure and should not be mistaken for active cell migration. To assess this, a group of animals were killed within 30 min of transplantation. In all these animals the transplanted cells were present in a 2-2n5 mm long fusiform core of cells oriented along the longitudinal axis of the cord and confined to the right ventral white matter. However, at later survival times (7 d and 15 d) the cells had migrated away from the point of injection (Fig. 4) . This migration occurred both radially and longitudinally, and without preference for either white or grey matter. Moreover, it was apparent from the increased number of cells present at 15 d compared with 7 d that the cells were dividing as well as migrating. By ultrastructural and immunocytochemical methods it was possible to show that the cells were migrating in the progenitor phenotype, and that the cells migrated through the parenchymal tissue of the spinal cord and not primarily in association with blood vessels or meninges.
Migrating CG4 cells contribute to the repair of remote areas of demyelination in X-irradiated spinal cord
In light of the observation described above, we next asked the question whether transplanted CG4 cells migrating in -irradiated spinal cord could enter and contribute to the repair of areas of demyelination remote from the point of transplantation. To do this we repeated the experiment described above, in which CG4 cells were transplanted into the right ventral white matter, but on this occasion an area of demyelination was induced in the dorsal funiculus by injection of EB. This arrangement was chosen since the passive spread of both suspensions and EB in spinal cord white matter is mainly parallel to the longitudinal axis of the constituent fibres. By choosing 2 separate funiculi the danger of transplanted cells entering the lesion by passive spread was overcome, and transplanted cells could only get to the lesion by active migration. By 7 d posttransplantation cells, had migrated throughout the spinal cord in a manner similar to that which occurred in unlesioned -irradiated tissue, and labelled cells were also seen within the lesion, although none of the axons had been myelinated. However, by 15 d posttransplantation, many of the demyelinated axons within the lesion had been remyelinated (Fig. 5 ). Since these experiments were undertaken in -irradiated tissue, which has no capacity for host-derived repair, this observation indicated that migrating CG4 cells could enter areas of demyelination and contribute to their repair. While the findings of this study were encouraging in terms of repairing multifocal areas of demyelination, they carried the proviso that the studies were all carried out in tissue that had been exposed to high levels of -irradiation.
Transplanted CG4 cells fail to survive and do not migrate when transplanted into normal adult spinal cord
To establish whether the observations recorded in experiments conducted in -irradiated spinal cord also applied to nonirradiated spinal cord, CG4 cells were transplanted into the right ventral white matter of nonirradiated spinal cord. The results of this experiment were dramatically different from those undertaken in -irradiated spinal cord. No cells were seen to migrate away from the point of introduction. Moreover, fewer cells were seen at 15 d posttransplantation than after 7 d. At both survival times the spread of cell was less than after 30 min. Indeed, cells were only seen in association with the mild degree of trauma induced in the white matter by the injection needle. This observation suggested that cells which had been introduced into normal tissue by the pressure of injection had not survived, and that survival was associated with tissue damage, albeit very mild (Fig. 6) .
Taken together, these results clearly show that while CG4 cells survive in lesioned tissue, they do not survive in normal tissue. The reason for this is not known at present but the events of development provide a possible explanation. Barres et al. (1992) have shown that during postnatal development of the rat optic nerve more oligodendrocyte progenitors are generated than are required to myelinate the optic nerve. Approximately half the oligodendrocyte progenitors generated differentiate into myelin-forming oligodendrocytes while most of the remainder undergo apoptotic cell death. A number of molecules, including platelet derived growth factor (PDGF), insulin-like growth factor-I (IGF-I), ciliary neurotrophic factor (CNTF) and neurotropin-3 (NT-3), are responsible for promoting survival of oligodendrocyte progenitors (Barres et al. 1992 (Barres et al. , 1993 (Barres et al. , 1994 . It would appear that the limited availability of these survival factors results in the death of supernumerary progenitors since a greater number of cells survive when additional survival factor is added to the neonatal optic nerve. Thus during the development of mature CNS white matter the appropriate number of oligodendrocyte lineage cells is achieved to some extent by limiting the availability of survival factor. By transplanting oligodendrocyte progenitor cells into adult white matter, one is adding to tissue cells that are superfluous to requirement. Such cells might therefore be expected to undergo apoptotic cell death in exactly the same manner as they would during normal development.
CG4 cells survive in -irradiated tissue and within demyelinating lesions, regardless of whether they enter lesions by migration or direct injection. Thus, in contrast to the situation occurring in normal tissue, -irradiated and damaged tissue support cell survival. This would indicate that survival factors are present in both these situations that are not present, or present to the same extent, in normal tissue. These factors are likely to include those which support oligodendrocyte progenitor survival during development and therefore include PDGF, IGF-I, CNTF and NT-3. Direct evidence for increased expression of these molecules in -irradiated tissue, demyelinating lesions or injection needle-induced trauma is limited. However, IGF-I levels are elevated in cuprizone-induced demyelination (Komoly et al. 1992) , while PDGF has been implicated in the astrocyte response that accompanies stabinduced lesions of the CNS (Takamiya et al. 1986 ) and may also be expressed at greater than normal levels in the early stages of remyelination of lysolecithininduced demyelinating lesions (McKay et al. 1995) . Exposure of the CNS to -irradiation has many effects which, although histologically subtle, could account for the difference in CG4 survival compared with nonirradiated tissue. For example, -irradiation leads to activation of both astrocytes and microglia, and to changes in the permeability of the blood-brain barrier (Chiang et al. 1993) . The net effect of these changes presumably leads to an elevation in the expression of molecules that promote survival.
Transplanted CG4 cells can enter areas of demyelination when transplanted close to lesions but not when transplanted at a distance
When CG4 cells are transplanted into the right ventral white matter in spinal cord in which an EB-induced demyelinating lesion is present in the dorsal funiculus, labelled cells can be identified within the lesion in a proportion of animals by 18 d posttransplantation. A similar result is achieved if the position of the lesion and the location of cell transplantation is reversed, with cells transplanted into the dorsal funiculus of spinal tissue in which a EB lesion is present in the ventral white matter. The absence of cells in the surrounding unlesioned tissue is in marked contrast to the situation that occurs in -irradiated tissue. If the cells are transplanted a single intervertebral space either caudal or cranial to the lesion, thereby increasing the distance over which transplanted cells need to travel to gain access to the demyelinated axons, then there is no migration away from the point of introduction and none enter the area of demyelination. It is clear from these results that only cells transplanted into the close vicinity of a lesion can enter the lesion, but will not do so if they are required to migrate through intervening normal tissue.
The observation that in some animals CG4 cells transplanted adjacent to areas of demyelination in nonirradiated tissue entered the lesion suggests that the presence of survival factors may not be confined by the boundaries of the lesion. Instead the presence of survival factors may form a diminishing gradient away from the lesion. Thus, one could imagine a penumbra of survival factors around a lesion, similar to the area of increased expression of the migrationsupporting PSA-NCAM which occurs around areas of demyelination (Oumesmar et al. 1995) , within which transplanted cells may survive and gain access to the lesion (summarised in Fig. 7) . Such a scenario might account for the observation made by other workers that remotely transplanted cells migrate into areas of demyelination (Gout & Dubois-Dalcq, 1993 ; Vignais et al. 1993) , although the failure to assess properly the passive spread of cells attributable to the injection procedure (Lipsitz et al. 1995 ; Olby et al. 1995) or establish the extent of the lesion (Jeffrey & Blakemore, 1995 ) make these studies difficult to interpret.
     - 
The well documented migratory behaviour of oligodendrocyte progenitors in vitro and in development raises the possibility that one could rely on the migratory behaviour of transplanted oligodendrocyte progenitors to remyelinate multifocal areas of demyelination throughout the CNS. Moreover, the production of recruitment signals from areas of demyelination that are responsible for orchestrating the inherent repair process might also cause transplanted cells to migrate preferentially towards lesions. This is a view for which there is some support in the literature (Gout et al. 1988 ; Gout & Dubois-Dalcq, 1993 ; Vignais et al. 1993 ; Baron-Van Evercooren et al. 1996) . However, the results described above, obtained using an oligodendrocyte progenitor line, suggest that transplanted oligodendrocyte progenitors do not survive in normal tissue and will therefore not migrate within the normal tissue that separates areas of demyelination. In this case, oligodendrocyte progenitor transplantation is only likely to be successful if cells are injected either directly into, or into the close vicinity of a lesion. It should be said that this conclusion is at variance with the conclusions reached by others (Gout & Dubois-Dalcq, 1993 ; Vignais et al. 1993 ; Baron-Van Evercooren et al. 1996) . There are a number of possible explanations for why the discrepancy exists. If, as we have argued above, pathological changes enhance the spinal cord's ability to support survival (and thus migration) of transplanted OPs, then experiments performed in essentially the same manner in the smaller spinal cord of the mouse might result in a proportionally greater degree of damage to the cord and hence increased survival of transplanted OPs over a larger area (Fig. 7) . Moreover, demyelinating lesions induced with the same (or greater) volume of gliotoxin will occupy a proportionately larger area of cord, increasing the danger that transplanted cells may inadvertently enter the lesion as a result of passive spread rather than active migration (Jeffrey & Blakemore, 1995) . It is also important that one considers all the possibilities of why the number of transplanted cells should be greatest within areas of demyelination following Fig. 7 . Summary of behaviour of OPs transplanted into nonirradiated adult spinal cord. When OPs are transplanted into lesions they survive and contribute to their repair. When they are transplanted into normal tissue they die. Between these 2 extremes is a penumbra of tissue which contains a diminishing gradient of factors, presumably similar to those in lesions and -irradiated tissue, which permits survival and migration. remote grafting. Preferential migration towards the lesion is certainly one explanation, but it needs to be distinguished form a situation in which transplanted cells enter the lesion as a result of nondirectional migration, and are then exposed within the lesion to local mitogens. However, one must also add the proviso regarding our own studies (Franklin et al. 1996 a) , in which we have used a cell line to model the behaviour of oligodendrocyte progenitors obtained from primary culture, that the behaviour of the latter may differ in some respects from the cell line. However, preliminary observations using primary OPs suggest that this is not the case (M. T. O'Leary & W. F. Blakemore, unpublished observation).
The observations made following transplantation into -irradiated tissue indicate that it is possible to manipulate the environment of the CNS so that it becomes supportive of oligodendrocyte progenitor survival and migration. More recent data have indicated that a dose of between 10 and 20 Gy is sufficient to convert a region of rat CNS from one that will not permit survival (and therefore migration) to one that will. Although one would not necessarily advocate the use of -irradiation, especially a dose as high as 40 Gy which will eventually lead to ischaemic necrosis, in clinical practice, nevertheless the principle of environment manipulation has been established.
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